Adverse Drug Reactions to Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Regimen: A 24-Week Prospective Study
- 31 August 2009
- journal article
- clinical trial
- Published by SAGE Publications in Journal of the International Association of Physicians in AIDS Care
- Vol. 8 (5), 318-322
- https://doi.org/10.1177/1545109709343967
Abstract
Background: Few studies have addressed the issue of adverse drug reactions with non-protease inhibitor (PI)-based antiretroviral therapy (ART) in resource-constrained settings. We studied prospectively the incidence of adverse drug reactions with generic ART among our patients.Keywords
This publication has 8 references indexed in Scilit:
- Clinical management of drug interaction with antiretroviral agentsCurrent Opinion in HIV and AIDS, 2008
- Spectrum of Adverse Events After Generic HAART in Southern Indian HIV-Infected PatientsAIDS Patient Care and STDs, 2008
- Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West AfricaAIDS, 2007
- Failure of Cetirizine to Prevent Nevirapine-Associated RashJAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
- Patterns and Correlates of Discontinuation of the Initial HAART Regimen in an Urban Outpatient CohortJAIDS Journal of Acquired Immune Deficiency Syndromes, 2003
- Failure of a Short-Term Prednisone Regimen to Prevent Nevirapine-Associated Rash: A Double-Blind Placebo-Controlled Trial: The GESIDA 09/99 StudyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Female sex and the use of anti-allergic agents increase the risk of developing cutaneous rash associated with nevirapine therapyAIDS, 2001
- Sex Differences in Nevirapine RashClinical Infectious Diseases, 2001